A coordinated synthesis and conjugation strategy for the preparation of homogeneous glycoconjugate vaccine candidates.
نویسندگان
چکیده
Glycoconjugates are the center of many therapeutic strategies and carbohydrate-based vaccines in particular hold great promise. The development of glycovaccines, however, can be hindered by the limited access offered by natural sources to homogeneous antigenic carbohydrates; efficient chemical synthesis offers an attractive route to pure samples of these carbohydrates. Furthermore, for an optimal immune response, the carbohydrate antigen should be conjugated to an immunogenic carrier, usually a protein. The synthesis and use of well-defined glycoprotein therapeutics and glycovaccines—uniform in sugar, site, and level of protein attachment—is rare and most constructs are prepared and administered as complex mixtures. 10] Even strategies that utilize pure synthetic glycan may employ non-selective methods for subsequent conjugation to a protein carrier. 7, 11, 12] Given the unknown influence of conjugation site on immunogenic response, it is remarkable that, to our knowledge, no homogeneous glycovaccine has been studied. To fully evaluate the structure–activity relationships (SARs) between glycoprotein and immunogenicity, we have initiated a program for the construction of such “pure” or uniform glycoconjugate vaccines. We report a coherent strategy for homogenous glycoprotein construction that coordinates both carbohydrate synthesis and conjugation methodology. This approach features glycosyl disulfides as versatile donors in complex carbohydrate synthesis, providing strategic access to glycosyl thiols that can be site-specifically attached to a protein carrier through a well-defined thioether linkage (Scheme 1).
منابع مشابه
Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7
Background: Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is an infectious zoonotic pathogen causing human infections. These infections, in some cases, can lead to hemolytic uremic syndrome and its life-threatening complications and even death worldwide. The first intimate bacterial adhesion, intimin (I), with its own receptor translocated intimin receptor (Tir) and E. coli secreted protein...
متن کاملStrain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease
Nontyphoidal Salmonellae, principally S. Typhimurium and S. Enteritidis, are a major cause of invasive bloodstream infections in sub-Saharan Africa with no vaccine currently available. Conjugation of lipopolysaccharide O-antigen to a carrier protein constitutes a promising vaccination strategy. Here we describe a rational process to select the most appropriate isolates of Salmonella as source o...
متن کاملSynthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate
Introduction: An effective vaccine against HCV infection is not available. The non-structural protein 3 (NS3) of the virus as an important immunogenic candidate has been utilized in various modules. Nanostructured polymers have been recently used for efficient vaccine and drug delivery. The aim of the current study was the synthesis of rNS3-G2 conjugate and preliminary evaluation of its immunog...
متن کاملCyclohexane-1,4-diyl bis (hydrogen sulfate) as an efficient homogeneous catalyst for one-pot multi-component synthesis of dihydropyrimidones via Biginelli reaction
A green methodology for the development of the synthesis of dihydropyrimidinones via a clean multi-component Biginelli reaction by using cyclohexane-1,4-diyl bis (hydrogen sulfate) (CDBH) as an effective catalyst in water and solvent-free conditions was reported. This sulfonated catalyst is an efficient and environmentally benign homogeneous catalysts which characterized by using different tech...
متن کاملExploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis
Glycoconjugate-based vaccines have proved to be effective at producing long-lasting protection against numerous pathogens. Here, we describe the application of bacterial protein glycan coupling technology (PGCT) to generate a novel recombinant glycoconjugate vaccine. We demonstrate the conjugation of the Francisella tularensis O-antigen to the Pseudomonas aeruginosa carrier protein exotoxin A u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Angewandte Chemie
دوره 50 18 شماره
صفحات -
تاریخ انتشار 2011